Intradialytic complement activation precedes the development of cardiovascular events in hemodialysis patients

Background: Hemodialysis (HD) is a life-saving treatment for patients with end stage renal disease. However, HD patients have markedly increased rates of cardiovascular morbidity and mortality. Previously, a link between the complement system and cardiovascular events (CV-events) has been reported....

Full description

Bibliographic Details
Main Author: Poppelaars, F (author)
Other Authors: Gaya Da Costa, M (author), Faria, B (author), Berger, S (author), Assa, S (author), Daha, M (author), Medina Pestana, J (author), Van, Son W (author), Franssen, C (author), Seelen, M (author)
Format: article
Language:eng
Published: 2018
Subjects:
Biocompatibility
C1-inhibitor
Cardiovascular risk
Complement
Hemodialysis
Innate immunity
Kidney
Online Access:https://hdl.handle.net/10216/126501
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/126501

Internet

https://hdl.handle.net/10216/126501

Similar Items